News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
657,046 Results
Type
Article (38439)
Company Profile (115)
Press Release (618484)
Multimedia
Podcasts (93)
Webinars (12)
Section
Business (172965)
Career Advice (2785)
Deals (32506)
Drug Delivery (117)
Drug Development (72923)
Employer Resources (160)
FDA (15888)
Job Trends (14654)
News (301139)
Policy (29063)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2719)
Academic (1)
Accelerated approval (52)
ADA (46)
Adcomms (31)
Allergies (202)
Alliances (43325)
ALS (231)
Alzheimer's disease (1879)
Antibody-drug conjugate (ADC) (515)
Approvals (16418)
Artificial intelligence (738)
ASCO (325)
Autoimmune disease (358)
Automation (62)
Bankruptcy (292)
Best Places to Work (12089)
BIO (71)
BIOSECURE Act (18)
Biosimilars (228)
Biotechnology (76)
Bladder cancer (203)
Brain cancer (74)
Breast cancer (817)
Cancer (6328)
Cardiovascular disease (499)
Career advice (2343)
Career pathing (48)
CAR-T (359)
CDC (56)
Celiac Disease (3)
Cell therapy (986)
Cervical cancer (55)
Clinical research (64833)
Collaboration (2274)
Commercialization (1)
Company closure (5)
Compensation (1519)
Complete response letters (81)
COVID-19 (2627)
CRISPR (119)
C-suite (1291)
Cystic fibrosis (163)
Data (8806)
Decentralized trials (2)
Denatured (22)
Depression (174)
Dermatology (94)
Diabetes (655)
Diagnostics (7292)
Digital health (63)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (352)
Drug pricing (179)
Drug shortages (24)
Duchenne muscular dystrophy (295)
Earnings (74052)
Editorial (72)
Employer branding (21)
Employer resources (145)
Events (111170)
Executive appointments (1184)
FDA (19975)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (21)
Frontotemporal dementia (35)
Funding (1870)
Gene editing (247)
Generative AI (56)
Gene therapy (752)
GLP-1 (974)
Government (4339)
Grass and pollen (7)
Guidances (417)
Healthcare (20187)
Hematology (190)
HIV (88)
Huntington's disease (57)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (107)
Immunology and inflammation (278)
Immuno-oncology (105)
Indications (219)
Infectious disease (2994)
Inflammatory bowel disease (233)
Inflation Reduction Act (12)
Influenza (143)
Intellectual property (326)
Interviews (552)
IPO (16338)
IRA (40)
Job creations (2878)
Job search strategy (1902)
JPM (55)
Kidney cancer (22)
Labor market (92)
Layoffs (526)
Leadership (51)
Legal (6406)
Liver cancer (95)
Longevity (36)
Lung cancer (819)
Lymphoma (466)
Machine learning (67)
Management (61)
Manufacturing (1115)
Marketing (4)
MASH (218)
Medical affairs (1)
Medical device (14631)
Medtech (14806)
Mergers & acquisitions (17596)
Metabolic disorders (1553)
mRNA (206)
Multiple sclerosis (199)
NASH (14)
Neurodegenerative disease (471)
Neuropsychiatric disorders (108)
Neuroscience (3537)
NextGen: Class of 2026 (6721)
Non-profit (4890)
Now hiring (69)
Obesity (656)
Opinion (319)
Ovarian cancer (242)
Pain (276)
Pancreatic cancer (354)
Parkinson's disease (416)
Partnered (33)
Patents (633)
Patient recruitment (790)
Peanut (68)
People (54356)
Pharmaceutical (30)
Pharmacy benefit managers (32)
Phase 1 (20247)
Phase 2 (28776)
Phase 3 (21398)
Pipeline (9915)
Policy (294)
Postmarket research (2023)
Preclinical (8329)
Press Release (62)
Prostate cancer (336)
Psychedelics (55)
Radiopharmaceuticals (354)
Rare diseases (1187)
Real estate (4957)
Recruiting (68)
Regulatory (24061)
Reports (36)
Research institute (2547)
Resumes & cover letters (454)
Rett syndrome (46)
RNA editing (24)
RSV (91)
Schizophrenia (182)
Series A (310)
Series B (236)
Service/supplier (6)
Sickle cell disease (127)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (40)
Startups (3092)
State (2)
Stomach cancer (10)
Supply chain (124)
Tariffs (76)
The Weekly (69)
Vaccines (1076)
Venture capital (109)
Weight loss (404)
Women's health (127)
Worklife (23)
Date
Today (109)
Last 7 days (491)
Last 30 days (2415)
Last 365 days (31247)
2026 (16545)
2025 (31179)
2024 (35937)
2023 (41282)
2022 (52115)
2021 (57035)
2020 (55561)
2019 (48727)
2018 (36624)
2017 (32098)
2016 (30367)
2015 (35471)
2014 (24629)
2013 (19205)
2012 (20726)
2011 (21532)
2010 (18623)
Location
Africa (783)
Alabama (99)
Alaska (7)
Arizona (296)
Arkansas (14)
Asia (38303)
Australia (6811)
California (14247)
Canada (3998)
China (1518)
Colorado (610)
Connecticut (632)
Delaware (435)
Europe (89411)
Florida (2154)
Georgia (467)
Hawaii (3)
Idaho (63)
Illinois (1174)
India (98)
Indiana (654)
Iowa (23)
Japan (594)
Kansas (134)
Kentucky (55)
Louisiana (60)
Maine (89)
Maryland (1670)
Massachusetts (10439)
Michigan (403)
Minnesota (781)
Mississippi (6)
Missouri (161)
Montana (36)
Nebraska (29)
Nevada (155)
New Hampshire (90)
New Jersey (3785)
New Mexico (33)
New York (3769)
North Carolina (1852)
North Dakota (11)
Northern California (7213)
Ohio (438)
Oklahoma (26)
Oregon (43)
Pennsylvania (2821)
Puerto Rico (31)
Rhode Island (51)
South America (1099)
South Carolina (87)
South Dakota (2)
Southern California (5681)
Tennessee (230)
Texas (2299)
United States (50716)
Utah (432)
Vermont (2)
Virginia (360)
Washington D.C. (76)
Washington State (1152)
West Virginia (3)
Wisconsin (149)
Wyoming (2)
657,046 Results for "recipharm ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
June 29, 2026
·
13 min read
Press Releases
AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
June 3, 2026
·
5 min read
Press Releases
Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
June 5, 2026
·
2 min read
Press Releases
Bulletin from the 2026 Annual General Meeting of Spago Nanomedical AB
June 11, 2026
·
3 min read
Press Releases
Bulletin from the Annual General Meeting in Cantargia AB (publ)
May 21, 2026
·
4 min read
Press Releases
Bulletin From Annual General Meeting in Senzime AB (publ)
May 19, 2026
·
6 min read
Press Releases
Biovica International AB Announces Change in Executive Management
May 5, 2026
·
2 min read
Press Releases
Cantargia AB to Host Webcast Covering Rights Issue, Loan Agreement, and Strategic Priorities
May 29, 2026
·
3 min read
Press Releases
BioInvent International AB: Interim Report January - March 2026
April 29, 2026
·
2 min read
Press Releases
AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS
June 10, 2026
·
5 min read
1 of 65,705
Next
